
zzso zzso cholesterol zzso remains the primary target of zzso zzso Achieving zzso goals as outlined by the National zzso Education Program Adult Treatment Panel III can be difficult with statins alone; therefore, zzso therapy is often indicated to reduce cardiovascular zzso zzso a potent inhibitor of zzso cholesterol zzso has been shown to be safe, tolerable and effective at lowering zzso zzso zzso cholesterol and zzso B, each of which has been correlated with improved clinical zzso alone or in combination with a zzso However, because of zzso trials that demonstrated mixed results about zzso plaque zzso via carotid zzso thickness and a concern about cancer risk, zzso role in zzso therapy has been zzso Currently, a large zzso controlled trial is in progress to answer if zzso improves clinical outcomes in patients with high-risk acute coronary zzso A smaller trial in patients with chronic kidney disease demonstrated reduced clinical events, including zzso zzso stroke and zzso for patients taking the combination of zzso and zzso versus those taking zzso or zzso zzso In this paper, we review the trials that have led to the zzso controversy and then discuss the possible role of zzso in specific patient populations until the results of ongoing clinical trials are zzso 

